Literature DB >> 6099214

Studies on leukotriene B4 omega-oxidation in human leukocytes.

M Nadeau, B Fruteau de Laclos, S Picard, P Braquet, E J Corey, P Borgeat.   

Abstract

The kinetics of the transformation of arachidonic acid into 5-lipoxygenase products in human blood leukocytes stimulated with the ionophore A23187 (2 microM) was studied using high performance liquid chromatography. The levels of 5-hydroxyeicosatetraenoic acid (5-HETE), leukotriene B4 (LTB4), delta 6-trans-LTB4, and leukotriene C4 (LTC4) were maximum after 4-5 min of incubation; at longer incubation times, the levels of delta 6-trans-LTB4 and LTC4 remained unchanged, whereas those of 5-HETE and LTB4 decreased rapidly. The disappearance of LTB4 was concomitant with the formation of omega-hydroxy-LTB4 and omega-carboxy-LTB4. When synthetic LTB4 was added to a suspension of unstimulated human leukocytes, a similar pattern of omega-oxidation products was observed. This omega-oxidation process showed some specificity for LTB4, as indicated by the slower reaction of three stereoisomers of LTB4. Studies with subpopulations of human blood cells and human plasma clearly indicated that the polymorphonuclear leukocytes were the main source of enzymic activity for the omega-oxidation of LTB4. The liquid chromatographic behaviors of natural omega-hydroxy-LTB4 and omega-carboxy-LTB4 were studied in two systems.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6099214     DOI: 10.1139/o84-168

Source DB:  PubMed          Journal:  Can J Biochem Cell Biol        ISSN: 0714-7511


  11 in total

1.  Omega-oxidized leukotriene B4 detected in the broncho-alveolar lavage fluid of patients with non-cardiogenic pulmonary edema, but not in those with cardiogenic edema.

Authors:  W Seeger; F Grimminger; M Barden; G Becker; J Lohmeyer; D Heinrich; H G Lasch
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 2.  Leukotrienes in inflammation.

Authors:  M A Bray
Journal:  Agents Actions       Date:  1986-10

Review 3.  Metabolism of leukotrienes.

Authors:  S Hammarström; L Orning; K Bernström
Journal:  Mol Cell Biochem       Date:  1985-11       Impact factor: 3.396

4.  Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro.

Authors:  M Laviolette; R Coulombe; S Picard; P Braquet; P Borgeat
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

5.  Inhibitory effects of MK-886 on arachidonic acid metabolism in human phagocytes.

Authors:  L Ménard; S Pilote; P H Naccache; M Laviolette; P Borgeat
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

6.  Role of Listeria monocytogenes exotoxins listeriolysin and phosphatidylinositol-specific phospholipase C in activation of human neutrophils.

Authors:  U Sibelius; E C Schulz; F Rose; K Hattar; T Jacobs; S Weiss; T Chakraborty; W Seeger; F Grimminger
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

7.  Metabolic disposition of leukotriene B4 (LTB4) and oxidation-resistant analogues of LTB4 in conscious rabbits.

Authors:  S Marleau; N Dallaire; P E Poubelle; P Borgeat
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

8.  Inflammatory lipid mediator generation elicited by viable hemolysin-forming Escherichia coli in lung vasculature.

Authors:  F Grimminger; M Thomas; R Obernitz; D Walmrath; S Bhakdi; W Seeger
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

9.  Omega-3 vs. omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation.

Authors:  Konstantin Mayer; Christine Fegbeutel; Katja Hattar; Ulf Sibelius; Hans-Joachim Krämer; Kai-Uwe Heuer; Bettina Temmesfeld-Wollbrück; Stephanie Gokorsch; Friedrich Grimminger; Werner Seeger
Journal:  Intensive Care Med       Date:  2003-07-25       Impact factor: 17.440

10.  Gram-Negative Bacteria Salmonella typhimurium Boost Leukotriene Synthesis Induced by Chemoattractant fMLP to Stimulate Neutrophil Swarming.

Authors:  Ekaterina A Golenkina; Svetlana I Galkina; Olga Pletjushkina; Boris Chernyak; Tatjana V Gaponova; Yulia M Romanova; Galina F Sud'ina
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.